[Information provided by:
ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]
|NCT01447810 : Constraint-Induced Movement Therapy in a Pediatric Oncology Population|
|Ages||Min: 2 Years Max: 7 Years|
- Diagnosed hemiplegia of an upper extremity as documented by physician or
rehabilitation clinician in the medical record
- Diagnosis of brain tumor
- English speaking
- Participant has demonstrated the ability in the past to move the elbow >70 degrees
and has some purposeful movement in the hand (ability to initiate a gross grasp).
- Parent/legal guardian is willing to give consent to participate in the study.
- Child is willing to give assent in the study if seven years old.
- Severe hemiplegia and resulting active range of motion deficits at the affected upper
extremity as defined by the following:
- < 30 degrees active shoulder flexion or abduction
- Inability to initiate active elbow flexion or extension.
- Inability to initiate movements at the of wrist, finger or thumb
- Uncontrolled seizures that interfere with daily activities, as this would interfere
with the participant's ability to fully participate in the CI Therapy program.
- Pain that significantly interferes with the participant's ability to fully
participate in the intensive therapy program. This includes pain related to
subluxation of the shoulder, as measured by a pain rating of 5/10 or greater on the
FACES or Numeric Pain Scale.
- Currently receiving oral or intravenous chemotherapy or radiation therapy.
- Inability or unwillingness of legal guardian to give written informed consent.
- Child is unwilling to give assent if seven years old
|Links||Permanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01447810
| Link to official Clinicaltrials.gov listing